tiprankstipranks
Trending News
More News >
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
US Market
Advertisement

Dianthus Therapeutics (DNTH) Ownership - Who Owns Dianthus Therapeutics?

Compare
359 Followers

Dianthus Therapeutics (DNTH) Ownership Overview

8.41%16.49%<0.01%8.76%66.34%
<0.01% Other Institutional Investors
8.76% ETFs
66.34% Public Companies and
Individual Investors
The ownership structure of Dianthus Therapeutics (DNTH) stock is a mix of institutional, retail, and individual investors. Approximately 25.25% of the company’s stock is owned by Institutional Investors, 8.41% is owned by Insiders, and 66.34% is owned by Public Companies and Individual Investors.
The ownership structure of Dianthus Therapeutics (DNTH) stock is a mix of institutional, retail, and individual investors. Approximately 16.49% of the company’s stock is owned by Institutional Investors, 8.41% is owned by Insiders, and 8.76% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$7461389
Jun 30, 2025
xxxxxxxxxxxxx
$14713210
Jun 30, 2025
xxxxxxxxxxxxx
$50434968

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,866,733Institution8.91%59,456,042
2,707,191Institution8.41%56,147,141
2,700,691Insider8.39%56,012,331
1,455,115Institution4.52%30,179,085
1,285,831Institution3.99%26,668,135
885,014Institution2.75%18,355,190
789,759Institution2.45%16,379,602
736,005Institution2.29%15,264,744
457,418Institution1.42%9,486,849
449,805Institution1.40%9,328,956

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,455,115Institution4.52%30,179,085
885,014Institution2.75%18,355,190
457,418Institution1.42%9,486,849
449,805Institution1.40%9,328,956
449,606Institution1.40%9,324,828
444,962Institution1.38%9,228,512
273,495Institution0.85%5,672,286
259,881Institution0.81%5,389,932
153,693Institution0.48%3,187,593
138,102Institution0.43%2,864,235

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
945,088Institution2.94%19,534,969
474,365Institution1.47%9,838,330
361,600Institution1.12%7,322,400
208,145Institution0.65%4,302,357
154,667Institution0.48%3,207,794
92,054Institution0.29%1,902,756
91,919Institution0.29%1,861,360
54,243Institution0.17%1,098,421
44,668Institution0.14%926,414
30,124Institution0.09%624,772

FAQ

Who Owns Dianthus Therapeutics (DNTH)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 8.41% is held by insiders, and 66.34% is held by retail investors.
    What percentage of Dianthus Therapeutics (DNTH) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Dianthus Therapeutics (DNTH) stock is held by institutional investors.
      What percentage of Dianthus Therapeutics (DNTH) stock is held by retail investors?
      According to the latest TipRanks data, approximately 66.34% of Dianthus Therapeutics (DNTH) stock is held by retail investors.
        Who owns the most shares of Dianthus Therapeutics (DNTH)?
        Peter Kolchinsky owns the most shares of Dianthus Therapeutics (DNTH).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis